Insights into Dyspareunia: From Diagnosis to Multimodal Treatment Approaches
DOI:
https://doi.org/10.12775/QS.2024.17.53126Keywords
dyspareunia, sexuality, pain management, sexual dysfunction, pelvic pain, sexual painAbstract
Introduction and Purpose:
Dyspareunia is a sexual disorder associated with pain in women. It refers to pain related to sexual intercourse. Pain can occur during penetration attempts, during penetration, during intercourse, and shortly after penetration. Studies conducted in the United States indicate that the problem of pain during intercourse affects as much as 10-20% of women. [1] In Poland, this number is estimated to be around 13%.[1] The aim of this review is to delve into the existing literature on the diagnosis of dyspareunia in women and to raise awareness of its extensive nature, emphasizing an interdisciplinary approach to patient care.
A Brief Description of the State of Knowledge:
The etiology of dyspareunia is multifactorial and may arise from pathological changes in the vulva and vagina, inflammatory changes, contact irritations, as well as vulvar conditions such as lichen sclerosus and flat. [3] Additionally, hormonal changes, pelvic floor injuries, postpartum gynecological procedures also play a significant role. Psychological factors such as trauma, anxiety, and depression are also important [4].
Conclusions:
Dyspareunia is a condition that significantly affects the quality of life of women in various ways, thus necessitating effective therapeutic approaches. Collaboration among diverse specialists such as gynecologists, sexologists, psychotherapists, psychiatrists, and physiotherapists is crucial. Further research focusing on multimodal strategies is needed to effectively tailor treatments and mitigate the systemic effects of chronic pain.
References
Lew-Starowicz M., Lew-Starowicz Z., Skrzypulec-Plinta V. (eds.). Sexual Disorders Related to Pain. In: Sexology. PZWL. Warsaw 2017: 978–983.
Phillips NA. The clinical evaluation of dyspareunia. Int J Impot Res. 1998 May;10 Suppl 2:S117-20. PMID: 9647973.
Canavan T, Heckman C. Dyspareunia in women. Breaking the silence is the first step toward treatment. Postgrad Med. 2000, 108, 149-152.
Sobhgol S, Alizadeli Charndabee S. Rate and related factors of dyspareunia in reproductive age women: a cross-sectional study. Int J Impot Res. 2007, 19, 88-94.
Jarząbek-Bielecka G. Sexual dysfunction caused not by organic disorders or somatic diseases. Dyspareunia and climacterium. Menopause Review 2012;11(5):428-430. doi:10.5114/pm.2012.31471.
Oettingen, Justyna. (2013). Sexual Dysfunctions — Approach Based on Cognitive Theory. Sexology Polska. 11. 68-75.
Sorensen J, Bautista KE, Lamvu G, Feranec J. Evaluation and Treatment of Female Sexual Pain: A Clinical Review. Cureus. 2018 Mar 27;10(3):e2379. doi: 10.7759/cureus.2379. PMID: 29805948; PMCID: PMC5969816.
Buster J., Kingsberg S., Kilpatrick Ch. ACOG Practice Bulletin number 119, Sexual Disorders in Women. Clinical Guidelines for Obstetricians and Gynecologists. Gynecology after Diploma 2012; 1: 69–78.
Weinberger JM, Houman J, Caron AT, Anger J. Female Sexual Dysfunction: A Systematic Review of Outcomes Across Various Treatment Modalities. Sex Med Rev. 2019 Apr;7(2):223-250. doi: 10.1016/j.sxmr.2017.12.004. Epub 2018 Feb 3. PMID: 29402732.
Oshinowo, Adeoti, and others, 'Dyspareunia and Vulvodynia', in Assia T. Valovska (ed.), Pelvic Pain Management (New York, 2016; online edn, Oxford Academic, 1 July 2016),
Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: Assessment and Treatment. J Sex Med. 2016 Apr;13(4):572-90. doi: 10.1016/j.jsxm.2016.01.020. Epub 2016 Mar 25. PMID: 27045258.
Cetera GE, Merli CEM, Boero V, Caia C, Vercellini P. Topical estrogens for the treatment of superficial dyspareunia related to genitourinary syndrome of menopause in women with a history of endometriosis: A clinical dilemma. Eur J Obstet Gynecol Reprod Biol. 2023 Sep;288:12-17. doi: 10.1016/j.ejogrb.2023.06.025. Epub 2023 Jun 26. PMID: 37421742.
Andrew T. Goldstein, Caroline F. Pukall, Candace Brown, Sophie Bergeron, Amy Stein, Susan Kellogg-Spadt, Vulvodynia: Assessment and Treatment, The Journal of Sexual Medicine , tom 13, wydanie 4, kwiecień 2016, strony 572–590
Moga MA, Dimienescu OG, Bălan A, Scârneciu I, Barabaș B, Pleș L. Therapeutic Approaches of Botulinum Toxin in Gynecology. Toxins (Basel). 2018 Apr 21;10(4):169. doi: 10.3390/toxins10040169. PMID: 29690530; PMCID: PMC5923335.
Parenti M, Degliuomini RS, Cosmi E, Vitagliano A, Fasola E, Origoni M, Salvatore S, Buzzaccarini G. Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review. Eur J Obstet Gynecol Reprod Biol. 2023 Dec;291:178-189. doi: 10.1016/j.ejogrb.2023.10.028. Epub 2023 Oct 27. PMID: 38353087.
Leo RJ. A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013 Aug;10(8):2000-8. doi: 10.1111/jsm.12200. Epub 2013 May 16. PMID: 23679335.
Brown CS, Bachmann GA, Wan J, Foster DC; Gabapentin (GABA) Study Group. Gabapentin for the Treatment of Vulvodynia: A Randomized Controlled Trial. Obstet Gynecol. 2018 Jun;131(6):1000-1007. doi: 10.1097/AOG.0000000000002617. PMID: 29742655; PMCID: PMC6020139.
Jeon Y, Kim Y, Shim B, Yoon H, Park Y, Shim B, Jeong W, Lee D. A retrospective study of the management of vulvodynia. Korean J Urol. 2013 Jan;54(1):48-52. doi: 10.4111/kju.2013.54.1.48. Epub 2013 Jan 18. PMID: 23362448; PMCID: PMC3556554.
Bachmann GA, Brown CS, Phillips NA, Rawlinson LA, Yu X, Wood R, Foster DC; Gabapentin Study Group. Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial. Am J Obstet Gynecol. 2019 Jan;220(1):89.e1-89.e8. doi: 10.1016/j.ajog.2018.10.021. Epub 2018 Oct 24. PMID: 30365922; PMCID: PMC6310649.
Wiffen PJ, Derry S, Bell RF, Rice ASC, Tölle TR, Phillips T, Moore RA. Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD007938. DOI: 10.1002/14651858.CD007938.pub4. Accessed 25 April 2024.
Ghaderi F, Bastani P, Hajebrahimi S, Jafarabadi MA, Berghmans B. Pelvic floor rehabilitation in the treatment of women with dyspareunia: a randomized controlled clinical trial. Int Urogynecol J. 2019 Nov;30(11):1849-1855. doi: 10.1007/s00192-019-04019-3. Epub 2019 Jul 8. PMID: 31286158; PMCID: PMC6834927.
Del Forno S, Arena A, Alessandrini M, Pellizzone V, Lenzi J, Raimondo D, Casadio P, Youssef A, Paradisi R, Seracchioli R. Transperineal Ultrasound Visual Feedback Assisted Pelvic Floor Muscle Physiotherapy in Women With Deep Infiltrating Endometriosis and Dyspareunia: A Pilot Study. J Sex Marital Ther. 2020;46(7):603-611. doi: 10.1080/0092623X.2020.1765057. Epub 2020 Jun 24. PMID: 32579077.
Murina F, Felice R, Di Francesco S, Oneda S. Vaginal diazepam plus transcutaneous electrical nerve stimulation to treat vestibulodynia: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:148-153. doi: 10.1016/j.ejogrb.2018.06.026. Epub 2018 Jun 27. PMID: 29960200.
Mira TAA, Yela DA, Podgaec S, Baracat EC, Benetti-Pinto CL. Hormonal treatment isolated versus hormonal treatment associated with electrotherapy for pelvic pain control in deep endometriosis: Randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:134-141. doi: 10.1016/j.ejogrb.2020.10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Klaudia Kołodziej, Dominika Mańdziuk, Patrycja Niewinna, Przemysław Zaroda, Paweł Dąda, Paweł Pawlik, Wojciech Kołodziej, Michał Żuchowski, Jakub Wawrzkowicz, Monika Korga
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 184
Number of citations: 0